Search for: "Pharmaceutical Staff" Results 21 - 40 of 1,296
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
4 Jan 2024, 3:58 am by Adams Lee
  Estimated Schedule of Investigations* December 29, 2023 – Petitions filed January 18, 2024 – DOC initiates investigation January 19, 2024 – ITC Staff Conference February 12, 2024 – ITC preliminary determination May 27, 2024 – DOC CVD preliminary determination (assuming extended deadline) (3/23/24 – unextended) July 26, 2024 – DOC AD preliminary determination (assuming extended deadline) (6/6/24 – unextended) December 8, 2024 – DOC… [read post]
3 Jan 2024, 3:51 am by Rob Robinson
These models are being utilized for innovative solutions such as predictive design in pharmaceuticals, automated financial analysis, and enhancing legal research and document management. [read post]
2 Jan 2024, 12:56 pm by Kevin LaCroix
Thus, by my tally there were 25 securities class action lawsuits filed against companies in the 283 SIC Code Industry Group (Drugs), including 17 in the 2834 SIC Code category (Pharmaceutical Preparations). [read post]
21 Dec 2023, 11:23 am by kblocher@hslf.org
The Ministry of Food and Drug Safety also announced its openness to receiving data from a range of modern non-animal approaches from companies applying for the approval of new pharmaceutical products. [read post]
11 Dec 2023, 5:05 am by Rob Robinson
Industry News Pharmaceutical Industry Prepares for Regulatory Shift as FTC Shifts Antitrust Tactics ComplexDiscovery Staff In response to the Biden administration’s intensified antitrust agenda, the pharmaceutical sector is bracing for a surge in regulatory challenges. [read post]
8 Dec 2023, 10:02 am by Cynthia Marcotte Stamer
  OCR’s announcement of the settlement quotes OCR Director Melanie Fontes Rainer as stating, “It is imperative that the health care industry be vigilant in protecting its systems and sensitive medical records, which includes regular training of staff and consistently monitoring and managing system risk to prevent these attacks. [read post]
4 Dec 2023, 7:49 am by Alden Abbott
As explained in a Sept. 27, 2023 public comment by the International Center for Law & Economics (ICLE), the proposed regulatory change “would increase compliance costs for merging parties generally, with disproportionate impact on small and first-time filers; they would impose additional burdens on agency staff; yet it is unlikely that they would provide countervailing benefits to competition and consumers. [read post]
30 Nov 2023, 8:25 am by Lebowitz & Mzhen
Rather than respond to the increased demands on pharmacists and pharmacy technicians by reducing work volume or hiring more staff, major pharmaceutical chains have increased the pressure on workers. [read post]
Farzona Kayumova is a staff correspondent for JURIST in Uzbekistan and a law student at Tashkent State University of Law. [read post]
24 Nov 2023, 10:18 am by Brian
Pharmaceutical Companies In cases where medication errors or defective drugs contribute to harm, pharmaceutical companies may face liability. [read post]
24 Nov 2023, 10:18 am by Brian
Pharmaceutical Companies In cases where medication errors or defective drugs contribute to harm, pharmaceutical companies may face liability. [read post]
24 Nov 2023, 10:18 am by Brian
Pharmaceutical Companies In cases where medication errors or defective drugs contribute to harm, pharmaceutical companies may face liability. [read post]
24 Nov 2023, 12:19 am by Kluwer Patent blogger
The declining search and examination quality of EPO patents is not only harmful because inventions are not protected but they also create a lot of uncertainty for the industry. [read post]
20 Nov 2023, 1:59 am by Kurt R. Karst
Claud —The word last week was that FDA is re-organizing the Office of Pharmaceutical Quality (OPQ) within the Center for Drug Evaluation and Research (CDER). [read post]
10 Nov 2023, 2:00 pm by Kluwer Patent blogger
In the meantime,  a new SUEPO app has been introduced to modernize communication to SUEPO members and EPO staff. [read post]
10 Nov 2023, 1:35 pm by Cynthia Marcotte Stamer
quickly to implement and communicate 2024 health spending account (“HFSA”), high deductible health plan amounts relevant to determining eligibility to contribute to a medical savings account (“MSA”), adoption credit and exclusion limits, and other inflation-adjusted limitations relevant to the annual enrollment, withholding and other year-end tax and benefit planning of workers and their families to assist workers to take into account these adjustments during 2024 benefit… [read post]
9 Nov 2023, 7:12 pm by Jason Noakes
  List of 78 Modern Awards affected Aboriginal and Torres Strait Islander Health Workers and Practitioners and Aboriginal Community Controlled Health Services Award 2020 (clause 22.3) Aircraft Cabin Crew Award 2020 (clause 19.4) Airline Operations – Ground Staff Award 2020 (clause 22.6) Alpine Resorts Award 2020 (clause 25.3) Aluminium Industry Award 2020 (clause 22.4) Ambulance and Patient Transport Industry Award 2020 (clause 22.7) Animal Care and Veterinary Services Award 2020… [read post]
9 Nov 2023, 1:48 pm by Cynthia Marcotte Stamer
  As a part of this work, she has continuously and extensively worked with domestic and international hospitals, health care systems, clinics, skilled nursing, long term care, rehabilitation and other health care providers and facilities; medical staff, accreditation, peer review and quality committees and organizations; billing, utilization management, management services organizations, group purchasing organizations; pharmaceutical, pharmacy, and prescription benefit… [read post]